Mesoblast reported -31307000 in EBIT for its fiscal semester ending in June of 2024.


Ebit Change Date
Avita Medical AUD -10272000 22.56M Dec/2024
Clinuvel Pharmaceuticals AUD 32.21M 14.41M Jun/2024
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Pacific Edge NZD -16918000 960K Mar/2024
Paradigm Biopharmaceuticals AUD -19930150 12.02M Jun/2023
PYC Therapeutics AUD -25838000 3M Dec/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Starpharma Holdings AUD -1034000 6.36M Dec/2023
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024